Olendalizumab, CAS [[2210314-30-8]] Preis auf Anfrage

Produktübersicht

• Artikelname: Olendalizumab, CAS [[2210314-30-8]] Preis auf Anfrage
• Artikelnummer: TGM-T77107
• Hersteller Artikelnummer: T77107
• Alternativnummer: TGM-T77107-5MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: ALXN1007 , Lendalizumab

Produktbeschreibung

Olendalizumab (ALXN-1007) is a humanized monoclonal antibody specifically targeting the complement component C5a. The compound binds to C5a, blocking its interaction with the C5aR (CD88) receptor, thereby inhibiting C5a-mediated inflammatory responses, neutrophil chemotaxis, and activation. In clinical and experimental research, Olendalizumab is investigated for treating complement-mediated disorders, such as sepsis, graft-versus-host disease (GVHD), and severe pneumonia or cytokine storms induced by viral infections (e.g., COVID-19).

Produkteigenschaften

• CAS Nummer: [2210314-30-8]
• Target-Kategorie: Complement System